These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 17689677
1. Clinicopathologic features of re-resected cases of intraductal papillary mucinous neoplasms (IPMNs). Yokoyama Y, Nagino M, Oda K, Nishio H, Ebata T, Abe T, Igami T, Nimura Y. Surgery; 2007 Aug; 142(2):136-42. PubMed ID: 17689677 [Abstract] [Full Text] [Related]
2. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Takahashi H, Nakamori S, Nakahira S, Tsujie M, Takahshi Y, Marubashi S, Miyamoto A, Takeda Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M. Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757 [Abstract] [Full Text] [Related]
3. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416 [Abstract] [Full Text] [Related]
4. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, Kanzaki A, Sugimoto H, Nomoto S, Takeda S, Morita S, Nakamura S, Nakao A. Surgery; 2010 Aug; 148(2):285-90. PubMed ID: 20434746 [Abstract] [Full Text] [Related]
5. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH, Heo JS, Cho BH, Yu HC, Yoon DS, Lee WJ, Lee HE, Kang GH, Lee JM. Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912 [Abstract] [Full Text] [Related]
6. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Hibi Y, Fukushima N, Tsuchida A, Sofuni A, Itoi T, Moriyasu F, Mukai K, Aoki T. Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458 [Abstract] [Full Text] [Related]
7. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S, Tani M, Kawai M, Ina S, Nishioka R, Miyazawa M, Fujita Y, Uchiyama K, Yamaue H. Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [Abstract] [Full Text] [Related]
8. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Sohn TA, Yeo CJ, Cameron JL, Hruban RH, Fukushima N, Campbell KA, Lillemoe KD. Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958 [Abstract] [Full Text] [Related]
9. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally? Nara S, Shimada K, Sakamoto Y, Esaki M, Kosuge T, Hiraoka N. J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402 [Abstract] [Full Text] [Related]
11. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Ishida M, Egawa S, Aoki T, Sakata N, Mikami Y, Motoi F, Abe T, Fukuyama S, Sunamura M, Unno M, Moriya T, Horii A, Furukawa T. Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241 [Abstract] [Full Text] [Related]
12. Surgical strategy for main pancreatic duct-type intraductal papillary mucinous neoplasm of the pancreas. Kuroki T, Adachi T, Ono S, Tanaka T, Kitasato A, Takatsuki M, Eguchi S. Hepatogastroenterology; 2012 Nov; 59(120):2631-4. PubMed ID: 22534541 [Abstract] [Full Text] [Related]
13. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M, Razo O, McGrath D, Pederzoli P, Fernández-Del Castillo C. Gastroenterology; 2007 Jul; 133(1):72-9; quiz 309-10. PubMed ID: 17631133 [Abstract] [Full Text] [Related]
14. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. Nagai K, Doi R, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Ogawa K, Uemoto S. J Hepatobiliary Pancreat Surg; 2009 Jul; 16(3):353-8. PubMed ID: 19280108 [Abstract] [Full Text] [Related]
19. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy. Fan F, Lai EC, Xie F, Yang JM, Xu F, Kan T, Shen RX, Yang XY, Lau Wan Y, Wu MC. Hepatogastroenterology; 2010 Jul; 57(99-100):635-9. PubMed ID: 20698241 [Abstract] [Full Text] [Related]
20. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Tanno S, Nakano Y, Nishikawa T, Nakamura K, Sasajima J, Minoguchi M, Mizukami Y, Yanagawa N, Fujii T, Obara T, Okumura T, Kohgo Y. Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227 [Abstract] [Full Text] [Related] Page: [Next] [New Search]